Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2023.
Stay updated with breaking news from Don Degolyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EBS earnings call for the period ending September 30, 2023.
Operator: Good afternoon, everyone. I am the operator for today’s call. Thank you for joining today as Emergent discusses the Operational and Financial Results for the Third Quarter of 2023.
All the makers of the 10 drugs subject to the inaugural Medicare drug price negotiations have opted into the talks with CMS.
GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with
GAITHERSBURG, Md., Oct. 02, 2023 -- Emergent BioSolutions Inc. today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial...